Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by RelevantStockon Aug 15, 2020 9:17am
200 Views
Post# 31412224

Perspective on the timeline and numbers

Perspective on the timeline and numbers
Here's a perspective on the timeline of the events.  We've been discussing for months that Q2 would not show covid testing revenue that much.
 
----
 
April 30th
Covid tests kits arrived at the SZLS lab
 
May 4th - enhanced partnership with PhlebFinders:
doing mostly private testing for families, network of freelancing phlebotomists
 
May 19th - partnership with UdoTest:
UdoTest are partnered with 30 labs if I remember, and they are trying to focus on rapid testing lately.  Not a major source of testing for Stagezero
 
May 21st - city of Alpharetta
Announced that they are testing 200 people, maybe more to come
 
Also in these days Ichor Blood services arrived as well.
 
----
 
These partnerships would reflect in my expectations the Q2 numbers for the month of June, about 1000 tests made for the month.
 
Again, since we are only guessing all the time here, it could be that Mercer asked them to scale up the lab capacity, and when they would be ready, they would send them tests requests according to their capacities.  It could explain why they are hiring now as it appears.  Also, 1000 tests per day has always been a capacity number, not an operational number.
 
I am not stating my other explanation, everything is always guessing and abstract information...
 
One thing for sure, 100 000$ revenue has nothing to do with an order of 250 000 tests for the year, unless they want to spread it on 250 months.  I want proofs and clear official statements that things are going in the right direction or not.  I have confidence in Tripp's plan, we need to have in-progress insights.
 
Bullboard Posts